Latest filing published 19 Jun 2006 for Acadia Pharmaceuticals INC, €143k.
Insider track record
No signal scores available.
Mark R. Brann: trading record in brief
All filings by Mark R. Brann on record concern Acadia Pharmaceuticals Inc. We count 10 filings; the first trade dates from 3 January 2006 and the latest from 16 June 2006.
On the market, this insider has only sold: 10 sales, €845k in total.
The latest filing, published on 19 June 2006, reports an open-market sale of €143k in Acadia Pharmaceuticals Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Mark R. Brann
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 20,000 shares@ US$9.05Common StockSEC:0001181431-06-037500:0
- 1,500 shares@ US$17.30Common StockSEC:0001181431-06-019250:0
- 12,500 shares@ US$17.41Common StockSEC:0001181431-06-019250:1
- 16,000 shares@ US$15.61Common StockSEC:0001181431-06-019250:2
- 5,000 shares@ US$15.85Common StockSEC:0001181431-06-019250:3
- 5,000 shares@ US$16.00Common StockSEC:0001181431-06-019250:4
- 6,000 shares@ US$10.08Common StockSEC:0001209191-06-002538:0
- 3,500 shares@ US$10.00Common StockSEC:0001209191-06-002272:0
- 3,000 shares@ US$10.00Common StockSEC:0001209191-06-002272:1
- 7,500 shares@ US$10.00Common StockSEC:0001209191-06-002272:2
10 of 10 declarations
